Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN114507177B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114507177B reveals a base-promoted synthesis route for isoindolinone intermediates using carbon dioxide, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.